Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.0850 (0.91%) ($11.0850 - $11.0850) on Fri. Mar. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.95% (three month average) | RSI | 66 | Latest Price | $11.0850(0.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 4.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(38%) IWC(37%) IWM(37%) | Factors Impacting BCRX price | BCRX will decline at least -3.475% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-8%) IGOV(-5%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.475% (StdDev 6.95%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $11.55(-4.03%) | 10 Day Moving Average | $11.3(-1.9%) | 20 Day Moving Average | $10.75(3.12%) | To recent high | -7.5% | To recent low | 57.3% | Market Cap | $1.956b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |